头MALT淋巴瘤发生率趋势和预后因素
Yaobin Lin1, Shan Liu2, Jianzhen Shen3
1Department of Radiation Oncology, Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fuzhou, Fujian, China.
Annals of hematology
|January 23, 2025
概括
头部和部粘膜相关的淋巴组织淋巴瘤 (HN-MALT) 的发病率在男性和女性下降. 一个新的诺莫格拉姆模型有助于对这种罕见的淋巴瘤进行预后评估.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 病理学 病理学 病理学
背景情况:
- 主要头部和部粘膜相关的淋巴组织淋巴瘤 (HN-MALT) 是一种罕见的恶性瘤,发病率和预后定义不佳.
- 了解HN-MALT趋势和预后因素对于临床管理至关重要.
研究的目的:
- 分析2000-2021年美国HN-MALT的发病率趋势.
- 确定整体存活率和淋巴瘤特定存活率的独立预后因素.
- 开发和验证HN-MALT预后的诺莫格拉姆预测模型.
主要方法:
- 利用了来自监测,流行病学和最终结果 (SEER) 数据库 (2000-2021) 的数据.
- 用于发病率趋势分析的员工结合点回归分析.
- 进行多变量考克斯回归分析,以确定预后因素并构建名录.
- 使用培训和验证队列 (7:3比率) 验证了名录.
主要成果:
- 总共分析了2517名HN-MALT患者.
- 在2016-2021年期间,HN-MALT发病率在两性 (APC -3.04%) 和60岁以上的个人 (APC -8.20%) 中显著下降.
- 男性性别,年龄≥60岁,白人种族和离婚/分居/寡居的婚姻状况被确定为生存的独立风险因素.
- 开发的名图表显示出极好的预测准确性,通过AUC,校准曲线和决策曲线分析进行验证.
结论:
- HN-MALT的发病率呈现下降趋势,特别是在老年人群中.
- 已开发出一个强大的诺莫格拉姆模型,用于对HN-MALT的预后评估.
- 这个名图可以为临床决策和患者管理提供有价值的指导.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


